Some New ESRD Drugs Would Get Two-Year Transition To Medicare Bundling – CMS Plan
This article was originally published in The Pink Sheet Daily
Executive Summary
Injectable drugs and biologics that don’t yet fit into existing categories for bundled physician payment would get separate reimbursement for at least two years, CMS proposes.